1. Home
  2. ESSA vs ATAI Comparison

ESSA vs ATAI Comparison

Compare ESSA & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESSA
  • ATAI
  • Stock Information
  • Founded
  • ESSA 1916
  • ATAI 2018
  • Country
  • ESSA United States
  • ATAI Germany
  • Employees
  • ESSA N/A
  • ATAI N/A
  • Industry
  • ESSA Banks
  • ATAI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESSA Finance
  • ATAI Health Care
  • Exchange
  • ESSA Nasdaq
  • ATAI Nasdaq
  • Market Cap
  • ESSA 192.5M
  • ATAI 214.8M
  • IPO Year
  • ESSA N/A
  • ATAI 2021
  • Fundamental
  • Price
  • ESSA $20.15
  • ATAI $1.52
  • Analyst Decision
  • ESSA
  • ATAI Strong Buy
  • Analyst Count
  • ESSA 0
  • ATAI 4
  • Target Price
  • ESSA N/A
  • ATAI $9.00
  • AVG Volume (30 Days)
  • ESSA 12.8K
  • ATAI 2.2M
  • Earning Date
  • ESSA 10-23-2024
  • ATAI 11-13-2024
  • Dividend Yield
  • ESSA 3.04%
  • ATAI N/A
  • EPS Growth
  • ESSA N/A
  • ATAI N/A
  • EPS
  • ESSA 1.81
  • ATAI N/A
  • Revenue
  • ESSA $68,480,000.00
  • ATAI $331,000.00
  • Revenue This Year
  • ESSA N/A
  • ATAI $44.72
  • Revenue Next Year
  • ESSA $6.92
  • ATAI N/A
  • P/E Ratio
  • ESSA $11.10
  • ATAI N/A
  • Revenue Growth
  • ESSA N/A
  • ATAI N/A
  • 52 Week Low
  • ESSA $15.29
  • ATAI $1.03
  • 52 Week High
  • ESSA $21.50
  • ATAI $2.85
  • Technical
  • Relative Strength Index (RSI)
  • ESSA 55.80
  • ATAI 57.65
  • Support Level
  • ESSA $19.35
  • ATAI $1.53
  • Resistance Level
  • ESSA $20.33
  • ATAI $1.95
  • Average True Range (ATR)
  • ESSA 0.64
  • ATAI 0.20
  • MACD
  • ESSA 0.01
  • ATAI 0.03
  • Stochastic Oscillator
  • ESSA 52.46
  • ATAI 52.22

About ESSA ESSA Bancorp Inc.

ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Share on Social Networks: